Layered GelMA/PEGDA Hydrogel Microneedle Patch as an Intradermal Delivery System for Hypertrophic Scar Treatment

增生性瘢痕 药物输送 自愈水凝胶 皮内注射 药理学 医学 材料科学 生物医学工程 外科 免疫学 纳米技术 高分子化学
作者
Zhi-Jing Chen,Xiaole Hu,Zhengjie Lin,Haoran Mao,Zhen Qiu,Ke-Rong Xiang,Tao Ke,Lihua Li,Lu Lu,Li‐Ling Xiao
出处
期刊:ACS Applied Materials & Interfaces [American Chemical Society]
卷期号:15 (37): 43309-43320 被引量:17
标识
DOI:10.1021/acsami.3c06800
摘要

Hypertrophic scar (HS) is an unfavorable skin disorder that typically develops after trauma, burn injury, or surgical procedures and causes numerous physical and psychological issues in patients. Currently, intralesional multi-injection of corticosteroid, particularly compound betamethasone (CB), is one of the most prevalent treatments for HS. However, injection administration could result in severe pain and dose-related side effects. Additionally, the vacuum therapeutic efficacy of this treatment relies on the level of expertise of the healthcare professional. To overcome the limitations of conventional injections, a new method that is convenient, painless, and self-administrable is urgently required. In this study, we developed a methacrylate gelatin (GelMA)/polyethylene glycol diacrylate (PEGDA) double-network hydrogel microneedle patch loaded with CB (CB-HMNP) as an intradermal delivery system for HS treatment. The double-network structure conferred the CB-HMNP with sufficient mechanical properties to successfully penetrate scar tissue while also helping to regulate the drug's sustained release rate. Subsequently, we confirmed that the CB-HMNP had a pronounced inhibitory effect on human HS fibroblasts (hHSFs), whereas drug-free HMNPs had no effect on hHSFs, indicating its high biocompatibility. In order to assess the therapeutic efficacy of CB-HMNPs, HS models of New Zealand rabbit ears were developed. The administration of CB-HMNP three times significantly decreased the scar elevation index (SEI), collagen I/III, and transforming growth factor-β1 (TGF-β1) protein. Therefore, the CB-HMNP may offer an administration pathway for the treatment of HS that is less painful, more convenient, less invasive, and sustain-released.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
明理完成签到,获得积分10
刚刚
12345完成签到,获得积分10
刚刚
拼搏菲鹰完成签到,获得积分10
1秒前
Fairy完成签到,获得积分10
1秒前
1秒前
小穆完成签到 ,获得积分10
2秒前
莫名完成签到,获得积分10
3秒前
4秒前
壮壮女士完成签到,获得积分10
4秒前
klicking完成签到,获得积分10
4秒前
书俭完成签到,获得积分10
5秒前
科研汪完成签到,获得积分10
5秒前
不配.应助山茶采纳,获得10
6秒前
6秒前
激昂的南烟完成签到 ,获得积分10
6秒前
炎魔之王拉格纳罗斯完成签到,获得积分10
7秒前
满意紫菜完成签到,获得积分10
8秒前
8秒前
DD完成签到,获得积分10
8秒前
高高万天完成签到,获得积分20
8秒前
Dr完成签到,获得积分10
9秒前
王Hope完成签到,获得积分10
9秒前
乐乐完成签到 ,获得积分10
10秒前
轻松的迎蓉完成签到,获得积分20
10秒前
fangze完成签到,获得积分10
10秒前
meta完成签到,获得积分10
11秒前
12秒前
Owen应助喜悦的琳采纳,获得10
12秒前
勺子爱西瓜完成签到,获得积分10
12秒前
sgpp应助顺遂采纳,获得10
13秒前
劼大大完成签到,获得积分10
13秒前
mushen完成签到,获得积分10
14秒前
iNk应助刘若鑫采纳,获得10
14秒前
SciGPT应助微笑的水桃采纳,获得10
14秒前
14秒前
执着夏山发布了新的文献求助10
15秒前
寒冷的寻菱完成签到,获得积分10
16秒前
miaorunquan完成签到,获得积分10
16秒前
16秒前
wang完成签到,获得积分10
16秒前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Foreign Policy of the French Second Empire: A Bibliography 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3147058
求助须知:如何正确求助?哪些是违规求助? 2798385
关于积分的说明 7828457
捐赠科研通 2454989
什么是DOI,文献DOI怎么找? 1306573
科研通“疑难数据库(出版商)”最低求助积分说明 627831
版权声明 601565